Here are three things to know:
1. One analyst rated the stock with a sell rating while three gave a hold rating.
2. The average one year price target issued by brokers who reported on the stock is $68.60.
3. NuVasive is a medical device company focused on creating minimally invasive spine products.
More device articles:
Medovex, AlfaMed, & more: 4 recent device company partnerships
Reprocessed medical devices market gaining traction — 4 observations
4 things to know about Intelligent Implant Systems
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
